Latest Trending News

Latest Trends And News Around The World
Menu
  • ENTERTAINMENT
  • WORLD
  • HEALTH
  • POLITICS
  • SPORTS
  • FINANCE
  • WEATHER

Coronavirus, also known as COVID-19, has spread to a number of countries around the world.

READ MORE ABOUT COVID -19 HERE
Home
HEALTH
(COVID-19) Coronavirus Treatment: Two Known Drugs Being Tested In U.S. In Race For Cure
HEALTH

(COVID-19) Coronavirus Treatment: Two Known Drugs Being Tested In U.S. In Race For Cure

March 19, 2020

Coronavirus Treatment: Two Known Drugs Being Tested In U.S. In Race For Cure.

U.S. researchers, following the lead of scientists in other countries, have launched studies to see whether widely-available, low-cost generic drugs can be used to help treat the illness caused by the new coronavirus.

There are currently no vaccines or treatments for the highly-contagious COVID-19 respiratory illness, so patients can only receive supportive care for now.

But a 1,500-person trial, led by the University of Minnesota, began this week to see whether malaria treatment hydroxychloroquine can prevent or reduce the severity of COVID-19. Two other trials are studying the blood pressure drug losartan as a possible treatment for the disease.

The malaria drug, also being tested in China, Australia and France, was touted earlier this week by Tesla (TSLA.O) Chief Executive Elon Musk, who recovered from malaria in 2000 after taking the medication.

Besides having a direct antiviral effect, hydroxychloroquine suppresses the production and release of proteins involved in the inflammatory complications of several viral diseases.

“We are trying to leverage the science to see if we can do something in addition to minimizing contacts,” said Dr. Jakub Tolar, dean of the University of Minnesota Medical School and vice president for clinical affairs. “Results are likely in weeks, not months.”

Most people infected with the new coronavirus develop only mild flu-like symptoms, but around 20 percent can have more severe disease that can lead to pneumonia requiring hospitalization.

The fast-spreading virus, which emerged in China in December and is now in more than 150 countries, has infected more than 214,000 and killed over 8,700 people worldwide, including at least 145 in the United States. Experts say it could take a year or more to have a preventive vaccine ready, so effective treatments are desperately needed.

A French team on Tuesday said initial results from a 24-patient trial of hydroxychloroquine showed that 25% of patients given the drug still carried the coronavirus after six days, compared with 90% of patients given a placebo.

Tolar said he bought 1,500 doses of hydroxychloroquine for a “laughable” amount of money. “We don’t need a multibillion-dollar investment. It is part of the beauty of this approach,” he said.

But he and others cautioned that people should not be using any prescription drugs without medical oversight.

“These treatments should be used only in hospitals by critical care specialists,” said Dr. Russel Buhr, critical care pulmonologist at the University of California, Los Angeles.

Also this week, the University of Minnesota launched two trials testing losartan – one to measure whether the hypertension drug reduces the risk of organ failure for COVID-19 patients who have been hospitalized, and another looking at whether the drug can limit the need for hospitalizations.

Losartan is an angiotensin receptor 1 (AT1R) blocker, which researchers say could play a role in blocking an enzyme used by the virus to bind to cells.

Pharmaceutical companies are also working to develop treatments for COVID-19, including Gilead Sciences Inc’s (GILD.O) experimental antiviral drug remdesivir, which is given to hospitalized patients via intravenous infusion over several days.

The New England Journal of Medicine earlier this month described how the drug was successfully used on the first patient infected by the novel coronavirus in the United States.

Results from a remdesivir trial in China could come early next month, while Gilead has begun two international trials of the drug that previously failed as a potential Ebola treatment. And the National Institutes of Health last month began testing it on patients in a U.S. trial.

“We are focusing on high risk patients,” said Dr. Andre Kalil, infectious disease specialist at the University of Nebraska Medical Center and the U.S. trial’s lead investigator. “Our hope is that remdesivir will show that patients will be improving faster.”

Companies including Regeneron Pharmaceuticals Inc (REGN.O), Eli Lilly and Co (LLY.N) and Takeda Pharmaceutical Co (4502.T) have begun to develop coronavirus treatment candidates, but human testing of their drugs has not yet started.

Anti-inflammatory drugs, like Regeneron’s Kevzara and Roche Holding AG’s (ROG.S) Actemra, have been used to treat the lung inflammation caused by COVID-19.

But in a disappointment, Chinese investigators reported this week that Kaletra, a combination HIV drug sold by AbbVie (ABBV.N), failed to improve outcomes for seriously ill COVID-19 patients.

Share
Tweet
Pinterest
Reddit
Stumble
Prev Article
Next Article
Tags:avigan bayer stock chloroquin chloroquine chloroquine coronavirus chloroquine covid 19 chloroquine for coronavirus chloroquine manufacturer chloroquine phosphate chloroquine phosphate tablets chloroquine side effects chloroquine tablets coronavirus cure news favipiravir gregory rigano hydroxychloroquine hydroxychloroquine coronavirus hydroxychloroquine side effects malaria drug mike pompeo plaquenil plaquenil coronavirus quinine quinine vs chloroquine sanofi stock

Related Articles

richard burr senator,senator burr,senator,loeffler,kelly loeffler,richard burr coronavirus,richard burr stock,richard burr insider trading,burr insider trading,insider trading,richard burr twitter,richard burr trump,ron johnson,sen richard burr,sen burr,richard burr news,inhofe,feinstein,jim inhofe,richard burr senate,richard burr north carolina,north carolina,senator loeffler,dianne feinstein,tucker carlson burr
Senator Richard Burr Sold Major Stocks As Law Makers Ignores …

Senator Richard Burr Sold Major Stocks As Law Makers Ignores Coronavirus Threat

coronavirus cases,covid-19 cases,covid-19 symptoms,coronavirus map,covid-19 map,italy coronavirus,covid-19 california,cdc coronavirus,china coronavirus,covid-19 updates,covid-19 test,us coronavirus cases,coronavirus vs covid-19,covid-19 cases in us,covid-19 florida,coronavirus tips,covid-19 vaccine,coronavirus vaccine,covid-19 live updates,coronavirus new york,covid-19 usa cases,coronavirus cure,sars,arizona coronavirus,covid-19 death toll
How Blood Of Coronavirus Survivors May Protect Others From Virus. …

COVID-19: How Blood Of Coronavirus Survivors May Protect Others From Virus

LATEST NEWS

  • See 10 Of The Most Expensive Guitars in the World
  • Kenny Rogers, Legendary Grammy Award Winning Country Singer Dies At Age 81
  • COVID-19: How Blood Of Coronavirus Survivors May Protect Others From Virus
  • Rosario Dawson To Cast As Star War’s Ahsoka Tano In ‘The Mandalorian’
  • Los Angeles Lakers, Boston Celtics Players Tests Positive For COVID-19
  • COVID-19 NEW YORK: Gov. Andrew Cuomo Orders New York Workers To Stay Home
  • COVID-19: Rishi Sunak Says Government Will Pay 80% Of Workers Wages During The Coronavirus Crisis

Latest Trending News

Latest Trends And News Around The World
Copyright © 2021 Latest Trending News